Endothelin receptor subtype distribution predisposes coronary arteries to damage

American Journal of Pathology

Volumn 157, Issue 1, 2000, Pages 123-134

  Louden, Calvert S ^a   Nambi, Ponnal ^a   Pullen, Mark A ^a   Thomas, Roberta A ^a   Tierney, Lauren A ^a   Solleveld, Henk A ^a   Schwartz, Lester W ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 (2 CARBOXYMETHOXY 4 METHOXYPHENYL) 1 (3,4 METHYLENEDIOXYPHENYL) 5 PROPOXY 2 INDANCARBOXYLIC ACID; ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST; VASOACTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; DOG; HEART RATE; HEMODYNAMICS; HISTOPATHOLOGY; IN SITU HYBRIDIZATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DENSITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TOXICOKINETICS; VASCULAR SMOOTH MUSCLE;

EID: 0033900809     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64524-5     Document Type: Article

References (51)

1. Cardiotoxicity of vasodilators and positive inotropic/vasodilating drugs in dogs: An overview
2. Effects of short-term and long term theobromine administration to male dogs
3. Cardiotoxicity of a new inotrope/vasodilator drug (SK and F 94120) in the dog
4. Acute cardiomyopathy induced by vasodilating antihypertensive agent minoxidil
5. Cardiovascular alterations in dogs treated with hydralazine
6. Coronary arterial lesions in dogs treated with an endothelin receptor antagonist
7. Coronary arterial lesions in dogs caused by endothelin receptor blockade are associated with regional differences in endothelin receptor distribution and blood flow
8. Pharmacological activities, regulation and possible roles in cardiovascular control
9. A novel potent vasoconstrictor peptide produced by vascular endothelial cells
10. Cloning and characterization of cDNA encoding human A-type endothelin receptor
11. Cloning and expression of a cDNA encoding an endothelin receptor
12. Endothelins: Circulating plasma levels and presence in other biologic fluids
13. Analysis of responses to endothelins in isolated porcine blood vessels by using a novel endothelin antagonist BQ153
14. Heterogeneity of endothelin-sarafotoxin receptors mediating contraction of pig coronary artery
15. The human endothelin family: Three structurally and pharmacologically distinct isopeptides predicted by three separate genes
16. The endothelin ET(B) receptor mediates both vasodilatation and vasoconstriction in vivo
17. Endothelial regulation of coronary vascular tone in vitro: Contribution of endothelin receptor subtypes and nitric oxide
18. The role of endothelin in the vessel wall
19. Endothelins and sarafotoxins: Physiological regulation, receptor subtypes and transmembrane signaling
20. Vasoconstrictor effect of endothelin on the canine coronary artery: Is a novel endogenous peptide involved in regulating myocardial blood flow and coronary spasm?
21. Venous smooth muscle contains vasoconstrictor ET(B)-like receptors
22. Potent vasoconstriction mediated by endothelin ET(B) receptors in canine coronary arteries
23. Endothelin ET(A) and ET(B) receptors mediate vascular smooth muscle contraction
24. Differential responsiveness of conduit and resistance coronary arteries to endothelin A and B receptor stimulation in anesthetized dogs
25. Inhibitory effects of TAK-044 on endothelin induced vasoconstriction in various canine arteries and porcine coronary arteries: A comparison with selective ET(A) and ET(B) receptor antagonists
26. SB 209670, a rationally designed potent nonpeptide endothelin receptor antagonist
27. Validity of microsphere depositions for regional myocardial flows
28. Fluorescent vs. radioactive microsphere measurement of regional myocardial blood flow
29. Validation of fluorescent-labeled microspheres for measurement of regional organ perfusion
30. Cardiovascular effects of radioactive microsphere suspensions and Tween 80 solutions
31. An optimized protocol for an in situ hybridization using PCR-generated 33P-labeled riboprobes
32. Characterization of canine renal endothelin receptor subtypes and function
33. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
34. Cloning and chromosomal localization of a human endothelin ETA receptor
35. Real time quantitative PCR
36. Detection of specific polymerase chain reaction product by utilizing the 5'-3' exonuclease activity of Thermus aquaticus DNA polymerase
37. Coronary arteriopathy in monkeys following administration of Cl-1020, an endothelin A receptor antagonist
38. A comparative study of minoxidil-induced myocardial lesions in beagle dogs and miniature swine
39. Whole body and regional hemodynamic of minoxidil in conscious dogs
40. Pathogenesis of cardiovascular alterations in dogs treated with minoxidil
41. Relationship between serum concentrations, hemodynamic effects and cardiovascular lesions in dogs treated with minoxidil
42. Effects of endothelin on the coronary vascular bed in open-chest dogs
43. Cloning and expression of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor
44. The human endothelin-B receptor gene: Structural organization and chromosomal assignment
45. Up-regulation of endothelin-B receptors in atherosclerotic human coronary arteries
46. Regulating expression and function of G-protein-linked receptors
47. The structure and specificity of endothelin receptors: Their importance in physiology and medicine
48. Alternative RNA splicing of the human endothelin-A receptor generates multiple transcripts
49. 1 cells
50. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor